Clinicopathological study of CD71/transferrin receptor 1 expression in colorectal tubular adenocarcinoma, tubular adenoma, and carcinoma in adenoma

  • Mochizuki Yuichiro
    Department of Pathology, Showa University School of Medicine Digestive Diseases Center, Showa University Koto Toyosu Hospital
  • Shiozawa Eisuke
    Department of Pathology, Showa University School of Medicine
  • Hojo Marin
    Department of Pathology, Showa University School of Medicine Digestive Diseases Center, Showa University Koto Toyosu Hospital
  • Sasaki Yosuke
    Department of Pathology, Showa University School of Medicine
  • Katagiri Atsushi
    Department of Medicine, Division of Gastroenterology, Showa University School of Medicine
  • Yoshida Hitoshi
    Department of Medicine, Division of Gastroenterology, Showa University School of Medicine
  • Uragami Naoyuki
    Digestive Diseases Center, Showa University Koto Toyosu Hospital
  • Yokoyama Noboru
    Digestive Diseases Center, Showa University Koto Toyosu Hospital
  • Inoue Haruhiro
    Digestive Diseases Center, Showa University Koto Toyosu Hospital
  • Yamochi-Onizuka Toshiko
    Department of Pathology, Showa University School of Medicine

Bibliographic Information

Other Title
  • 大腸管状腺癌および管状腺腫におけるCD71/transferrin receptor 1発現と病理組織診断への応用に関する臨床病理学的検討
  • ―腺腫内癌におけるCD71発現の比較検討を用いて―

Description

CD71/transferrin receptor 1, a crucial type Ⅱ transmembrane glycoprotein, plays a vital role in regulating iron uptake and cell proliferation, and it is commonly found in various cancer cells. This study aimed to assess CD71 expression through immunohistochemistry in colorectal tubular adenoma, tubular adenocarcinoma, and carcinoma in adenoma, with the objective of determining the usefulness of CD71 immunohistochemistry in diagnosing colorectal cancer histopathologically. Subjects and Methods: The study included 28 colorectal tubular adenomas and 34 tubular adenocarcinomas obtained through endoscopic resection. Among the tubular adenocarcinomas, 16 (47%) were categorized as intra-adenoma carcinomas, and the adenoma and adenocarcinoma sections were evaluated separately. CD71 expression was evaluated across five grades: Grade 0 indicated no staining, Grade 1 denoted positive staining limited to the cellular membrane, Grade 2 represented weak and focal cytoplasmic positivity, Grade 3 indicated diffuse cytoplasmic positivity in portion of the tumor, and Grade 4 indicated intense and diffuse cytoplasmic positivity throughout the tumor. Statistical analysis involved the χ-square test and Fisher exact test for independence to compare differences between groups. Results: CD71 expression in adenoma was Grades 0, 1, 2, and 3 in 12, 13, 2, and 1 cases, respectively, with the majority falling into Grade 0-1 (n=25) and no Grade 4 cases observed. Conversely, CD71 expression in adenocarcinoma was Grades 1, 2, 3, and 4 in 6, 6, 9, and 13 cases, respectively, with diffuse positivity being predominant and no Grade 0 cases identified. Among the 16 cases of carcinoma in adenoma, the adenoma portion exhibited low CD71 expression (Grades 0, 1, or 2) in all instances, whereas 10 of these cases showed elevated CD71 expression (Grades 3 or 4) in the adenocarcinoma portion. Conclusions: CD71/transferrin receptor 1 expression levels were notably lower in colorectal tubular adenomas compared to tubular adenocarcinomas. Moreover, CD71 demonstrated differential expression patterns between the adenoma and adenocarcinoma portions of carcinoma in adenoma originating from the same tumor clone, indicating that CD71 immunohistochemistry might serve as an additional tool in the histopathological diagnosis of colorectal tumors.

Journal

Details 詳細情報について

  • CRID
    1390300833108781312
  • DOI
    10.14930/jshowaunivsoc.84.242
  • ISSN
    2188529X
    2187719X
  • Text Lang
    ja
  • Data Source
    • JaLC
  • Abstract License Flag
    Disallowed

Report a problem

Back to top